HNGE HNGE Weighted Average Exercise Price of Outstanding Options

Weighted Average Exercise Price of Outstanding Options at other companies

Globus MedicalGMED

——

Revenue$182.3M+47.2%

Gross profit$154.2M+53.9%

Operating income$32.1M+144%

Net income$35.1M+105%

EPS (diluted)$0.41-68.7%

Cash & equivalents$188.1M-35.2%

Total debt$7.0M—

Total equity$111.7M+136%

Total assets$728.8M—

Operating cash flow$43.1M+775%

CapEx$83.0K+62.7%

Free cash flow$43.0M+782%

Market cap$5.37B—

Enterprise value$5.19B—

P/S8.3×—

Gross margin80.8%+1.5pp

Operating margin-85.8%—

Net margin-83.9%—

FCF margin32.3%—

Return on equity551.8%—

Debt / equity0.1×—

Current ratio1.3×—

Reported directly by HNGE in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: HNGE’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is HNGE's weighted average exercise price of outstanding options?: HNGE (HNGE) reported weighted average exercise price of outstanding options of $1.68 in Q1 2026.
What does weighted average exercise price of outstanding options mean?: This metric calculates the average price at which holders of outstanding stock options can purchase company shares. It provides context on the 'in-the-money' status of employee compensation packages. When compared to the current market price, it helps assess the alignment between employee incentives and shareholder value.